Answer
Stopping anticoagulant activity exposes the patient's existing clotting risk. Andexanet alfa also inhibits tissue factor pathway inhibitor, which can increase thrombin generation.
Sources for this answer
- Ondexxya 200 mg powder for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.